RxSource Announces Major U.S. Expansion with West Deptford Facility Move

RxSource, a Canadian-headquartered leader in clinical trial supply services, is proud to announce a significant expansion of its U.S. operations. The company will relocate from its current site in Secaucus, New Jersey, to a substantially larger facility in West Deptford. This move will increase RxSource’s U.S. operational footprint to over 48,000 sq.ft, significantly boosting capacity to meet rising client demand and creating numerous job opportunities in the local community.

In the coming weeks, RxSource will begin outfitting the West Deptford facility with advanced infrastructure, including a state-of-the-art air handling system and specialized cold chain packaging and labeling rooms. The new facility is projected to be fully operational by late 2024, with new job listings to be announced shortly.

Yussuf Goolam, CEO of RxSource, remarked, “This expansion is a monumental milestone for RxSource. It underscores our commitment to excellence and reflects the hard work and dedication of our global team. Our client’s increased demand has driven us to this exciting phase of growth, and we are thrilled to invest in a facility that will support our ambitious future.  Together, with the strength of our team, our clients, our vendors and stakeholders this facility will allow us to achieve our purpose to Improve the Lives of Patients.”

Rhys Evans, Senior Vice President of Global Operations, added, “The launch of our new facility marks a pivotal moment for RxSource. The upcoming fit-out will dramatically enhance our capacity with additional temperature-controlled services.  Situated within a prime pharmaceutical and distribution hub, this facility offers unparalleled opportunities for future expansion, ensuring we are exceptionally well-positioned for continued growth.”